Purchase Order 75N92025P00379
Award Date 9/16/25
Potential Completion Date 11/1/25
Potential Value $290K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), awarded a $11,335.87 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract is for the provision of various Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with accompanying consumables, support services, and bioinformatics products. This delivery order award is under a broader...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $149,987.33 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables, support, and maintenance services. This award does not have a small business set-aside designation....
- The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), awarded a firm fixed-price purchase order to Illumina, Inc. to provide service and support for the agency's NextSeq 2000 DNA sequencing instruments. The $25,959 contract has a completion date of September 28, 2025 and does not have a set-aside designation. Illumina is a manufacturer of genomic analysis instruments and reagents, and has previously supported sequencing needs across various...
- This contract was awarded by the National Human Genome Research Institute, a civilian agency, to Illumina, Inc., a for-profit manufacturer of goods. The contract is for the purchase of an Illumina MiSeq System, a genetic sequencing instrument, for $95,931.00 on a firm fixed price basis. The contract has no set-aside designation. Based on Illumina's history of federal contract awards, the company has provided a range of sequencing instruments, reagents, and bioinformatics products to support...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $149,627.88, was awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is a delivery order and is a firm fixed-price arrangement, with no set-aside designation. Illumina has previously provided a range of sequencing systems, reagents,...
- The U.S. National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH), awarded a $102,215.22 firm fixed-price delivery order contract to Illumina, Inc. This order is part of a larger Indefinite Delivery Contract between Illumina and the Department of the Navy Bureau of Medicine and Surgery, valued up to $3.3 million, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. The...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $5,906.00. The contract does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. Under this order, Illumina will provide various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, sample prep kits,...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
- This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
- This is a firm fixed-price purchase order contract awarded to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies, by the National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH). The $25,959 contract is for the provision of NEXTSEQ2000 sequencing services and has an ultimate completion date of September 28, 2026. The contract was awarded on September 29, 2025 and does not utilize...
The U.S. National Human Genome Research Institute (NHGRI), a civilian agency, awarded a firm-fixed-price purchase order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and consumables, for the purchase of Illumina MiSeq i100 Plus Systems. The $290,026.10 contract has an ultimate completion date of November 1, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a key technology provider for federal scientific and diagnostic research initiatives, holding Indefinite Delivery Contracts with the U.S. Department of Agriculture and the Department of Veterans Affairs for the provision of advanced sequencing platforms and related products and services.
Generated 9/30/25, 9:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $290.0k | 9/16/25 |